Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein - PubMed (original) (raw)

Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein

C Hadjiagapiou et al. Nucleic Acids Res. 1994.

Free PMC article

Abstract

Mammalian small intestinal apolipoprotein B (apo B) mRNA undergoes posttranscriptional cytidine deamination with the production of an in frame stop codon and the translation of apo B48. We have isolated a cDNA from human jejunum which mediates in vitro editing of a synthetic apo B RNA template upon complementation with chicken intestinal S100 extracts. The cDNA specifies a 236 residue protein which is 69% identical to the apo B mRNA editing protein (REPR) cloned from rat small intestine [Teng, B., Burant, C. F. and Davidson, N. O. (1993) Science 260, 1816-1819] and which, by analogy, is referred to as HEPR. HEPR does not contain the carboxyl-terminus leucine zipper motif identified in REPR but contains consensus phosphorylation sites as well as the conserved histidine and both cysteine residues identified as a Zn2+ binding motif in other cytidine deaminases. The distribution of HEPR mRNA was predominantly confined to the adult small intestine with lower levels detectable by reverse-transcription polymerase chain reaction amplification in the stomach, colon and testis. These differences in the structure and distribution of the human as compared to the rat apo B mRNA editing protein suggest an important evolutionary adaptation in the mechanisms restricting apo B48 production to the small intestine.

PubMed Disclaimer

References

    1. Biochem Biophys Res Commun. 1993 Sep 30;195(3):1204-10 - PubMed
    1. J Biol Chem. 1993 Oct 5;268(28):20709-12 - PubMed
    1. J Lipid Res. 1994 Feb;35(2):340-50 - PubMed
    1. J Biol Chem. 1993 Feb 5;268(4):2288-91 - PubMed
    1. Cell. 1987 Sep 11;50(6):831-40 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources